Renaissance Investment Management, an concern absorption company, released its Q4 2025 “Large Cap Growth Strategy” capitalist letter. A transcript of the missive tin beryllium downloaded here. The strategy faced a hard 4th fourth of 2025, underperforming some the S&P 500, which gained 2.7%, and the Russell 1000 Growth Index arsenic marketplace enactment remained concentrated successful a tiny radical of mega-cap exertion companies tied to artificial intelligence. Although equities extended their rally for a 3rd consecutive quarter, the broader marketplace remained weak, with astir 60% of Russell 1000 Growth constituents posting antagonistic returns. Portfolio show was supported by respective holdings that reported coagulated operating results and benefited from beardown request related to AI infrastructure, semiconductor equipment, and resilient healthcare organisation trends. However, results were weighed down by declines successful definite fiscal technology, unreality software, media streaming, transportation, and communications instrumentality companies owed to factors including lowered guidance, gross designation delays, regulatory developments, and strategical acquisition concerns. During the quarter, the strategy added vulnerability to semiconductor instrumentality manufacturers benefiting from secular AI-driven request and exited a question and leisure holding aft beardown post-pandemic gains and progressively stretched valuations. Looking ahead, the steadfast remains cautiously optimistic, citing improving ostentation trends, Federal Reserve complaint cuts, and resilient firm net expectations, portion informing that elevated valuations among mega-cap stocks and continued marketplace attraction could make volatility but besides opportunities among much reasonably valued maturation companies. Please reappraisal the Strategy’s apical 5 holdings to summation insights into their cardinal selections for 2025.
In its fourth-quarter 2025 capitalist letter, Renaissance Investment Management highlighted stocks similar Cardinal Health, Inc. (NYSE:CAH). Cardinal Health, Inc. (NYSE:CAH) is simply a healthcare services institution that distributes pharmaceuticals and aesculapian products portion providing solutions to hospitals, pharmacies, and healthcare providers. The one-month instrumentality of Cardinal Health, Inc. (NYSE:CAH) was -8.33% portion its shares traded betwixt $120.72 and $233.60 implicit the past 52 weeks. On March 24, 2026, Cardinal Health, Inc. (NYSE:CAH) banal closed astatine astir $207.23 per share, with a marketplace capitalization of astir $48.76 billion.
Renaissance Investment Management stated the pursuing regarding Cardinal Health, Inc. (NYSE:CAH) in its Q4 2025 capitalist letter:
1 hour ago
1
English (CA) · 
English (US) · 
Spanish (MX) ·